Stay up-to-date on the advancing field of HCT with short summaries and links to the most relevant published research.
Cappelli B, et al. Haematologica – The youngest of three age-based patient cohorts (age 0-5 years) in a study of 736 patients with sickle cell disease (SCD) undergoing HLA-identical sibling hematopoietic cell transplantation (HCT) experienced 4-year event-free survival of 93%, results the researchers characterized as “excellent.”
Subscribe to E-News
Receive new research summaries monthly.